Tech Company Financing Transactions
Mission Bio Funding Round
Mission Bio, based in San Francisco, secured $10 million in investment from Mayfield Fund and private investors.
Transaction Overview
Company Name
Announced On
10/18/2017
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Mayfield Fund (Lead Investor) (Ursheet Parikh)
Proceeds Purpose
With the Series A investment and launch of the Tapestri platform, Mission Bio also begins its Custom Panel Grant Program which will provide researchers a grant to build a custom panel on the Tapestri platform and collaborate with Mission Bio for single-cell mutational profiling.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6000 Shoreline Ct. 104
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Mission Bio provides tools for the study of cellular heterogeneity in human health and life science research. Our approach relies on proprietary microfluidic droplet technology to deliver rapid and cost-effective solutions for molecular analysis of single cells.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/18/2017: Digital Asset venture capital transaction
Next: 10/18/2017: Covera venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs